Futures Flat Ahead Of Quad Witching Volume Surge
Lots of noise, But no chorus
Gold rises in Asian session amid recovery uncertainty
Rapid 90-minute COVID-19 test shown to be highly accurate
Will the UK really join the CPTPP free-trade bloc in Asia-Pacific?
Barclays Latest Global Megabank To Suffer Trading Floor COVID-19 Outbreak
Gatwick becomes first UK airport to roll out UV cleaning system for security trays
Futures Slide After Fed "Not-Dovish-Enough", Tech Tumbles On Reflation Rotation Fears
Lilly’s antibody therapy cuts hospitalisation rates in COVID-19
COVID - Why Terminology Really, Really Matters
China Poses "The Greatest Threat To World Order": UK Military Intel Chief
British-made surgical PPE device rolls out free to NHS
Pound Rallies on Brexit Optimism, Later Falls on FOMC Decision
NIH Raises Concerns About Potential Safety Issues Associated with AstraZeneca Vaccine
The experience economy will not fully recover – consumers will pay to perform in future instead
3 "Perfect 10" Dividend Stocks Yielding at Least 5%
Futures Push Higher Ahead Of Fed Decision, Retail Sales
Inditex returns to post second quarter earnings and soars on the stock market
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial
Europe's Zombie Firms Are Multiplying Like Never Before
Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy
Daily Market News: Apple stock falls flat after raft of product announcements
Asia Waits For the Federal Reserve
Japan’s new prime minister Suga set to continue ‘Abenomics’
Backlash After UK Policing Minister Encourages People To Spy On Neighbours For "COVID Contraventions"
How The British Government Is Wading Into The Swamp Of Despotism... One Muzzle At A Time
Nature: Humanity at a crossroads, UN warns in new Global Biodiversity Outlook report
Eyeing emergency use of COVID-19 drug, Humanigen partners with Lonza to make it
NIH ‘very concerned’ about serious side effect in AstraZeneca's PhIII Covid-19 trial